Once deemed dangerous and illegal, psychedelic compounds have been rediscovered by the scientific, medical and psychiatric communities as research reveals their capacity to help patients with a range of maladies. With investors beginning to flood this new market with capital, will Big Pharma join in, or try to squash a nascent revolution of the mind?